GreenBio Competitors

Winning in clean technologies is complex—new technologies emerge, policies shift, and it’s hard to know which opportunities will scale and which will fail. By blending human intelligence, proprietary data, and the global network we’ve cultivated for more than 20 years, we deliver insights you can trust and guidance you can act on. Whether you’re shaping corporate strategy, scaling innovation, investing capital, or designing policy, your Cleantech Group membership gives you the full picture and the connections that unlock growth. In a fast-moving, high-stakes environment, we help you see clearly, act confidently, and lead the transition.

BioHarvest Sciences Inc. (Nasdaq: BHST) is a public biotech company that has developed a patented Botanical Synthesis platform technology capable of growing the active and beneficial compounds in fruit & plants, at an industrial scale, without the need to grow the plant itself. BioHarvest has invested 17 years and >$100M to develop our Botanical Synthesis Technology, which produces unique and patentable botanical compositions which contain a “target optimized” combination of the phyto-medicinal compounds (with high solubility and bio-availability) found in the original plant. No other company has developed a commercially viable plant cell culture platform at the industrial scale of BioHarvest. BioHarvest is focused on leveraging this platform technology across the following business units: 1. Biologics+ CDMO Services: BioHarvest is leveraging its Botanical Synthesis technology to allow global pharmaceutical, nutrition, cosmetics, and nutraceutical partners to develop proprietary compounds with unmatched predictability and consistency, manufactured at industrial scale under exclusive partnerships. 2. Direct to Consumer Business Anchored in Science: BioHarvest has built its own direct to consumer business of propriety botanical compositions. The first product, VINIA® was launched into the US in 2021 and has now exceeded 60,000 daily users (>$50M USD Revenue since 2021 launch). VINIA® contains multiple polyphenols, including Piceid Resveratrol, with an amount in each daily 400mg capsule that is equivalent to 1,000 grapes, resulting in a powerful nutraceutical that has been clinically proven (in a published double-blind placebo-controlled study), to significantly increase dilation of arteries. This increased dilation of arteries improves blood flow and the delivery of oxygen and nutrients to the body, tissue & organs.

The Greenwood Publishing Group is one of the world's leading publishers of reference titles, academic and general interest books, texts, books for librarians an...